Rahul Bhargava, Director and Head of Hematology, Hematooncology, and Stem Cell Transplant at Fortis Health Care, shared on LinkedIn:
“Understanding Immune Recovery After Transplant: The Next Frontier in BMT
A successful transplant is not the end of the journey – it is the beginning of a new phase where the body’s immune system gradually rebuilds itself.
Understanding immune reconstitution after bone marrow transplantation and CAR-T therapy is becoming one of the most important advances in modern hematology.
It helps us predict infections, prevent graft-versus-host disease (GVHD), preserve the life-saving graft-versus-leukemia effect, and ultimately personalize post-transplant care.
We warmly invite you to join us on 21st August 2026 at Fortis Memorial Research Institute, Gurugram, for this unique scientific meeting, expertly organized by Dr. Aastha Gupta .
Together, we will explore how advanced immune monitoring is translating laboratory science into real-world clinical practice, enabling smarter decisions, reducing unnecessary investigations and treatment costs, and improving outcomes for our patients.
The future of transplantation lies not only in performing the transplant successfully, but in understanding how the immune system recovers afterwards.
Let us learn together how immune monitoring is reshaping the care of patients undergoing BMT and CAR-T therapy.
Looking forward to welcoming you for an engaging afternoon of science, collaboration, and meaningful discussion.”
Other articles about CAR-T therapy and BMT on OncoDaily.
